首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.
【2h】

Construction of antagonist dose-response curves for estimation of pA2-values by Schild-plot analysis and detection of allosteric interactions.

机译:通过Schild图解分析和变构相互作用的检测来构建用于估计pA2值的拮抗剂剂量反应曲线。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. One aim of this paper is to show an alternative approach for the determination of antagonist affinity estimates, KB and pA2, by construction and evaluation of antagonist dose-response curves (DRCs), using the curve-fitting programme, ALLFIT. 2. Parallel antagonist DRCs were derived by vertical analysis of families of conventional agonist DRCs in the presence and absence of an antagonist at a certain agonist concentration above its ED50. The latter represents a chosen, i.e. fixed dose-ratio (DR). The antagonist concentration that reduces an agonist effect to its Emax/2 was termed Bx. It corresponds to B, the fixed antagonist concentration, tested to obtain DR-1, conventionally. 3. The dissociation constant was calculated as KB = Bx/DR-1, analogous to the conventional approach (KB = B/DR-1). Likewise, pA2-values were estimated by plotting log Bx, obtained by the alternative approach, vs log (DR-1) in an 'alternative Schild plot'. 4. Experimental agonist DRCs from our laboratory and from the literature were analysed and KB- and pA2-values obtained by the alternative approach were compared with those obtained by the conventional method. The results showed a very good agreement (correlation) between the pA2-values obtained by either method (slope = 1.02, r = 0.99, n = 9), in agreement with theoretical DRCs. 5. Besides estimation of KB and pA2, antagonist DRCs were also evaluated qualitatively. The most important finding was that allosteric antagonists or competitive antagonists with an allosteric component, such as gallamine, showed a significant reduction in the maximum of the antagonist DRCs (Imax). The evaluation of antagonist DRCs appears to be a sensitive procedure to detect allosteric interactions.(ABSTRACT TRUNCATED AT 250 WORDS)
机译:本文的一个目的是展示一种替代方法,该方法使用曲线拟合程序ALLFIT通过构建和评估拮抗剂剂量反应曲线(DRC)来确定拮抗剂亲和力估计值KB和pA2。 2.通过在存在和不存在高于ED 50的一定激动剂浓度的拮抗剂的情况下,通过对常规激动剂DRC家族的垂直分析得出平行的拮抗剂DRC。后者代表选择的,即固定的剂量比(DR)。将激动剂作用降低至其Emax / 2的拮抗剂浓度称为Bx。常规上,它对应于B,即固定的拮抗剂浓度,经测试以获得DR-1。 3.与常规方法类似(KB = B / DR-1),解离常数计算为KB = Bx / DR-1。同样,pA2值是通过在“替代的Schild图”中绘制通过替代方法获得的log Bx与log(DR-1)的关系来估算的。 4.分析了来自我们实验室和文献的实验性激动剂DRC,并将通过替代方法获得的KB和pA2值与通过常规方法获得的KB和pA2值进行了比较。结果表明,通过两种方法获得的pA2值(斜率= 1.02,r = 0.99,n = 9)之间都具有很好的一致性(相关性),与理论DRC一致。 5.除了KB和pA2的估计外,还对定性评估了拮抗DRC。最重要的发现是变构拮抗剂或具有变构成分的竞争性拮抗剂(例如没食子胺)显示出最大的拮抗剂DRC(Imax)明显降低。拮抗DRC的评估似乎是检测变构相互作用的灵敏方法。(摘要截断为250字)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号